Adjuvant chemotherapy for stage II colorectal cancer: The time is right!

Nature Clinical Practice Oncology

Volumn 2, Issue 7, 2005, Pages 364-369

  Midgley, Rachel ^a   Kerr, David J ^b  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Adjuvant chemotherapy; Colon cancer; Stage II; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; LEVAMISOLE; OXALIPLATIN;

BOLUS INJECTION; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; DIARRHEA; DISEASE FREE SURVIVAL; DRUG INFUSION; HUMAN; NEUTROPENIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; SENSORY NEUROPATHY; STOMATITIS; ADJUVANT CHEMOTHERAPY; COLORECTAL TUMOR; HISTORY; PATHOLOGY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; COLORECTAL NEOPLASMS; HISTORY, 20TH CENTURY; HUMANS; NEOPLASM STAGING;

EID: 23844435327     PISSN: 17434254     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncponc0228     Document Type: Review

References (26)

1. Faivre-Finn C et al. (2002) Colon cancer in France: Evidence for improvement in management and survival. Gut 51: 60-64
2. Buyse M et al. (1988) Adjuvant therapy of colorectal cancer. Why we still don't know. JAMA 259: 3571-3578
3. Moertel CG et al. (1990) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322: 352-358
4. Moertel CG et al. (1995) Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. J Clin Oncol 13: 2936-2943
5. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) Investigators (1995) Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 345: 939-944
6. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators (1999) Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer J Clin Oncol 17: 1356-1363
7. Haller DG et al. (1998) Flurouracil, leucovorin and levamisole adjuvant therapy for colon cancer: Five year final report of INT-0089 [abstract]. Proc Am Soc Clin Oncol 17: A256
8. QUASAR Collaborative Group (2000) Comparison of flourouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: A randomised trial Lancet 355: 1586-1596
9. Cassidy J et al. (2004) Capecitabine versus bolus 5FU/leucovorin as adjuvant therapy for colon cancer (the X-ACT study): Efficacy results of a phase III trial [abstract]. Proc Am Soc Clin Oncol 23: A3509
10. Andre T et al. (2003) Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: Results of a randomized trial. J Clin Oncol 21: 2896-2903
11. Saini A et al. (2003) Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer. Br J Cancer 88: 1859-1865
12. Andre T et al. (2004) Multicenter international study of oxaliplatin/ 5-fluorouracil/leucovorin in the adjuvant treatment of colon cancer. N Engl J Med 350: 2343-2351
13. Saltz LB et al. (2004) Irinotecan plus fluorouracil/leucovorin (IFL) versus fluorouracil/leucovorin alone (FL) in stage III colon cancer (intergroup trial CALGB C89803) [abstract]. J Clin Oncol 22 (Suppl): A246
14. Van Cutsem E et al. (2005) Randomised phase III trial comparing infused irinotecan/5-flurouracil/folinic acid versus 5FU/FA in stage III colon cancer patients (PETACC III) [abstract]. Proc Am Soc Clin Oncol
15. Mamounas E et al. (1999) Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: Results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04). J Clin Oncol 17: 1349-1355
16. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators (1999) Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. J Clin Oncol 17: 1356-1363
17. Gill S et al. (2004) Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: Who benefits and by how much? J Clin Oncol 22: 1797-1806
18. Benson AB III et al. (2004) American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22: 3408-3419
19. Kerr DJ et al. (2000) Adjuvant chemotherapy with 5-fluorouracil, L-folinic acid and levamisole for patients with colorectal cancer: non-randomised comparison of weekly versus four-weekly schedules - less pain, same gain. QUASAR Colorectal Cancer Study Group. Ann Oncol 11: 947-955
20. Grey RG et al. for the QUASAR Collaborative Group. (2004) QUASAR: A randomized study of adjuvant chemotherapy versus observation including 3238 colorectal cancer patients [abstract]. J Clin Oncol 22 (Suppl): aS3501
21. Hawkins N et al. (2002) CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology 122: 1376-1387
22. Witzig TE et al. (1991) DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C coloractal adenocarcinoma. Cancer 68: 879-888
23. Zhou W et al. (2001) Counting alleles reveals a connection between chromosome 18q loss and vascular invasion. Nat Biotechnol 19: 78-81
24. Khan ZA et al. (2000) P53 mutations in primary and metastatic tumors and circulating tumor cells from colorectal carcinoma patients. Clin Cancer Res 6: 3499-3504
25. Wang Y et al. (2004) Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J Clin Oncol 22: 1564-1571
26. Saltz LB et al. (2004) Irinotecan plus fluorouracil/leucovorin versus fluorouracil/leucovorin alone in stage III colon cancer. Proc Am Soc Clin Oncol 23: A3500